Experimental cancer vaccine combo targets tough tumors in early trial
Disease control
Recruiting now
This early-phase study tests a new treatment called PeptiCRAd-1, a virus-based cancer vaccine, combined with the immunotherapy drug pembrolizumab. The goal is to see if this combination is safe and can boost the immune system to fight several types of solid tumors, including mela…
Phase: PHASE1 • Sponsor: Valo Therapeutics Oy • Aim: Disease control
Last updated May 17, 2026 02:05 UTC